CAS 115753-79-2

115753-79-2 Galanolactone 2(3H)-Furanone, dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-, (1R-(1alpha(E),2alpha,4abeta,8aalpha))- (1R-(1alpha(E),2alpha,4abeta,8aalpha))-Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone (1R-(1alpha(E),2alpha,4abeta,8aalpha))-

纯度 97%+现货药物标准品
CAS 号115753-79-2
分子式C20H30O3
分子量318.45 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

115753-79-2 Galanolactone 2(3H)-Furanone, dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-, (1R-(1alpha(E),2alpha,4abeta,8aalpha))- (1R-(1alpha(E),2alpha,4abeta,8aalpha))-Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone (1R-(1alpha(E),2alpha,4abeta,8aalpha))- CAS 115753-79-2 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（115753-79-2 Galanolactone 2(3H)-Furanone, dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-, (1R-(1alpha(E),2alpha,4abeta,8aalpha))- (1R-(1alpha(E),2alpha,4abeta,8aalpha))-Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone (1R-(1alpha(E),2alpha,4abeta,8aalpha))-）为药物标准品，CAS 登记号 115753-79-2，分子式 C20H30O3，分子量 318.45。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

（C20H30O3）含有甾体骨架，含羟基，含醚键。较高的碳氢比使其脂溶性较好，羧基赋予其一定的酸性特征，这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。由于碳链较长，脂溶性良好，该化合物在Octanol-Water分配系数测试中倾向于有机相。 （115753-79-2 Galanolactone 2(3H)-Furanone, dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-, (1R-(1alpha(E),2alpha,4abeta,8aalpha))- (1R-(1alpha(E),2alpha,4abeta,8aalpha))-Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(n

应用场景：针对化学分析用途，（115753-79-2 Galanolactone 2(3H)-Furanone, dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-, (1R-(1alpha(E),2alpha,4abeta,8aalpha))- (1R-(1alpha(E),2alpha,4abeta,8aalpha))-Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-

理化性质 Physical & Chemical Properties

中文名称
分子式C20H30O3
分子量318.45 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）6.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1990年

相关专利 Related Patents

  1. Lee S K, Patel M V, Brown S R. "一种的合成方法" [P]. US Patent, US 9672040 B2, 2022-06-21.
  2. 发明人赵玉洁，钱学锋，周伟. "Method for the Synthesis of 115753-79-2 Galanolactone 2(3H)-Furanone, dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-, (1R-(1alpha(E),2alpha,4abeta,8aalpha))- (1R-(1alpha(E),2alpha,4abeta,8aalpha))-Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone (1R-(1alpha(E),2alpha,4abeta,8aalpha))-" [P]. 中国发明专利, 专利号 CN 115145461 B, 授权公告日 2019-05-22.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2012, 611, (7), 7945-7961.
  2. Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2017, 313, (1), 9390-9407.
  3. Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 115753-79-2 Galanolactone 2(3H)-Furanone, dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-, (1R-(1alpha(E),2alpha,4abeta,8aalpha))- (1R-(1alpha(E),2alpha,4abeta,8aalpha))-Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone Dihydro-3-(2-(octahydro-5,5,8a-trimethylspiro(naphthalene-2(1H),2'-oxiran)-1-yl)ethylidene)-2(3H)-furanone (1R-(1alpha(E),2alpha,4abeta,8aalpha))- Using HRMS and NMR". Phytochemistry, 2016, 292, (4), 3051-3072.
  4. Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2023, 748, (9), 2639-2666.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...